Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of myelodysplastic syndrome

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 11, 2009, Pages 1110-1112

  Pinheiro, R F ^a   Chauffaille, M L L F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

FISH; G banding; Myelodysplastic syndrome

Indexed keywords

ARTICLE; CENTROMERE; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION; KARYOTYPE; MALE; MALIGNANT TRANSFORMATION; METAPHASE; MYELODYSPLASTIC SYNDROME;

EID: 71049146351     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009001100018     Document Type: Article

References (20)

1. Mufti GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 2004; 17: 543-557.
2. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088. (Pubitemid 27132124)
3. Rigolin GM, Bigoni R, Milani R, Cavazzini F, Roberti MG, Bardi A, et al. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia 2001; 15: 1841-1847. (Pubitemid 33114989)
4. Sole F, Luno E, Sanzo C, Espinet B, Sanz GF, Cervera J, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005; 90: 1168-1178. (Pubitemid 41375276)
5. Romeo M, Chauffaille ML, Silva MR, Bahia DM, Kerbauy J. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients. Leuk Res 2002; 26: 993-996. (Pubitemid 35287209)
6. Cherry AM, Brockman SR, Paternoster SF, Hicks GA, Neuberg D, Higgins RR, et al. Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leuk Res 2003; 27: 1085-1090. (Pubitemid 36960027)
7. Trost D, Hildebrandt B, Muller N, Germing U, Royer-Pokora B. Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics. Leuk Res 2004; 28: 171-177. (Pubitemid 37487997)
8. Feitosa Pinheiro R, Maranhao Bahia D, Artur Flores Pelloso L, Guimaraes Vaz De Campos M, De Lourdes Chauffaille M. Isolated interstitial 9q deletion in a case of unclassifiable myelodysplastic syndrome. Cancer Genet Cytogenet 2004; 153: 183-184. (Pubitemid 39592154)
9. Pinheiro RF, Silva MR, Chauffaille ML. The 5q- syndrome and autoimmune phenomena: report of three cases. Leuk Res 2006; 30: 507-510. (Pubitemid 43254975)
10. Pinheiro RF, Chauffaille ML, Silva MR. A rare case of acute myeloid leukemia evolving from a myelodysplastic syndrome with der(19)t(1;19). Cancer Genet Cytogenet 2006; 169: 181-183. (Pubitemid 44287099)
11. Pinheiro RF, Chauffaille ML, Silva MR. Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genet Cytogenet 2006; 166: 189-190.
12. Pinheiro RF, Moreira Ede S, Silva MR, Greggio B, Alberto FL, Chauffaille Mde L. FLT3 mutation and AML/ETO in a case of myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesis. Leuk Res 2007; 31: 1015-1018. (Pubitemid 46856721)
13. Pinheiro RF, de Sa Moreira E, Silva MR, Alberto FL, Chauffaille Mde L. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Cancer Genet Cytogenet 2008; 183: 89-93. (Pubitemid 351707708)
14. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
16. Chauffaille ML, Yamamoto M, Moncau JE, Braga GW, Souto EX, Kerbauy J. [Cytogenetic abnormalities as prognostic factors in acute myeloid leukemia]. Rev Assoc Med Bras 1996; 42: 200-204.
17. Mitelman F. Catalog of chromosome aberrations in cancer. 4th edn. New York: Wiley-Liss; 2005.
18. List AF, Baker AF, Green S, Bellamy W. Lenalidomide: targeted anemia therapy for myelodysplastic syndromes. Cancer Control 2006; 13 (Suppl): 4-11. (Pubitemid 46148104)
19. Panani AD, Pappa V. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes. In Vivo 2005; 19: 979-981. (Pubitemid 41631498)
20. Chen L, Li J, Zhu Y, Qiu H, Pan J, Wang R, et al. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China. Exp Oncol 2007; 29: 299-303. (Pubitemid 351236320)